Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.

Gwendal Le MassonGuilhem SoléClaude DesnuelleEmilien DelmontMarc Gauthier-DarnisSophie PugetIsabelle Durand Zaleski

Published in: Brain and behavior (2018)

The switch from hospital-based to home-based IVIg treatment for patients with immune neuropathy represents potentially significant savings in the management of the disease.

Keyphrases

healthcare
multiple sclerosis
emergency department
drug induced